2018 Ross Prize in Molecular Medicine — Genetics of Neurodevelopmental Disorders
Tuesday, June 5, 2018, 12:30 PM - 5:30 PM
The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York
The Ross Prize in Molecular Medicine was established in conjunction with the Feinstein Institute for Medical Research and Molecular Medicine to recognize biomedical scientists whose discoveries transformed the way medicine is practiced. The awardees are midcareer researchers who have made a significant impact in the understanding of human disease pathogenesis and/or treatment. Moreover, it is anticipated that they will continue to make profound advances in the general field of molecular medicine.
The 2018 Ross Prize in Molecular Medicine will be awarded to Dr. Huda Y. Zoghbi for her research unveiling the genetic and molecular basis of Rett syndrome and spinocerebellar ataxia, enabling novel therapeutic strategies for these devastating diseases. Her discovery of the mutational driver of Rett syndrome also lead to the elucidation of its role in other neurological impairments, ranging from learning disabilities to autism. Complemented by fundamental studies in neurodevelopment, Dr. Zoghbi continues to pursue the complex molecular processes driving the pathogenesis of some of the most devastating neurological conditions.
June 05, 2018
Welcome and Introductory Remarks
Registration and Refreshments
Session I: 2018 Ross Prize in Molecular Medicine Presentation and Lecture
2018 Ross Prize in Molecular Medicine Announcement and Presentation
2018 Ross Prize in Molecular Medicine Acceptance
Genetic and Neurophysiological Approaches to Tackle Neurodevelopmental Disorders
Session II: Healthy and Pathologic Neurodevelopment